Although not a brain-specific marker, NT-proBNP levels have been suggested as an optimal biomarker for cardioembolic stroke diagnosis in the acute phase [18,19,20,21]; our data demonstrate that NT-proBNP is a significant variable in differentiating IS and HS in the hyperacute phase of stroke. This evidence concerns the gene NPPB and cardioembolic stroke.